Proteolytic Activation of Protein Kinase C δ by an ICE/CED 3-like Protease Induces Characteristics of Apoptosis by Ghayur, Tariq et al.
 
2399
 
J. Exp. Med. 
 
Ó
 
 
 
The Rockefeller University Press • 0022-1007/96/12/2399/06 $2.00
Volume 184 December 1996 2399–2404
 
Brief Deﬁnitive Report
 
Proteolytic Activation of Protein Kinase C 
 
d
 
 by an ICE/CED
3-like Protease Induces Characteristics of Apoptosis
 
By Tariq Ghayur,
 
*
 
 Margaret Hugunin,
 
*
 
 Robert V. Talanian,
 
*
 
Sheldon Ratnofsky,
 
*
 
 Christopher Quinlan,
 
*
 
 Yutaka Emoto,
 
‡
 
Pramod Pandey,
 
‡
 
 Rakesh Datta,
 
‡ 
 
Yinyin Huang,
 
‡
 
Surender Kharbanda,
 
‡
 
 Hamish Allen,
 
*
 
 Robert Kamen,
 
*
 
Winnie Wong,
 
*
 
 and Donald Kufe
 
‡
 
From 
 
*
 
BASF Bioresearch Corporation, Worcester, Massachusetts 01605; and 
 
‡
 
Division of Cancer 
Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
 
Summary
 
Recent studies have shown that protein kinase C (PKC) 
 
d
 
 is proteolytically activated at the on-
set of apoptosis induced by DNA-damaging agents, tumor necrosis factor, and anti-Fas anti-
body. However, the relationship of PKC
 
d
 
 cleavage to induction of apoptosis is unknown. The
present studies demonstrate that full-length PKC
 
d
 
 is cleaved at DMQD
 
330
 
N to a catalytically
active fragment by the cysteine protease CPP32. The results also demonstrate that overexpres-
sion of the catalytic kinase fragment in cells is associated with chromatin condensation, nuclear
fragmentation, induction of sub-G1 phase DNA and lethality. By contrast, overexpression of
full-length PKC
 
d
 
 or a kinase inactive PKC
 
d
 
 fragment had no detectable effect. The findings
suggest that proteolytic activation of PKC
 
d
 
 by a CPP32-like protease contributes to pheno-
typic changes associated with apoptosis.
 
T
 
he protein kinase C (PKC) family consists of multiple
subspecies that possess a conserved catalytic domain.
The classic or group A isoforms (
 
a
 
, 
 
b
 
, and 
 
g
 
) require Ca
 
2
 
1
 
for activity and contain cysteine-rich motifs that confer
phospholipid-dependent binding of diacylglycerol (1). The
group A PKCs are cleaved at the third variable region (V
 
3
 
)
by the neutral proteases, calpains I and II, to catalytically
active fragments (2). Recent studies have demonstrated that
the Ca
 
2
 
1
 
-independent 
 
d
 
 isoform, and not the group A
PKCs, is selectively cleaved at V
 
3
 
 to a catalytically active
fragment in cells induced to undergo apoptosis (3, 4). Inhi-
bition of apoptosis by overexpression of Bcl-2 or Bcl-x
 
L
 
 is
associated with a block of PKC
 
d
 
 cleavage (3, 4). The find-
ing that PKC
 
d
 
 is cleaved at a site (DMQD/N) adjacent to
aspartic acid has supported the potential involvement of as-
partate-specific cysteine proteases which are known to be
activated during apoptosis.
The nematode Ced-3 cysteine protease is related to the
mammalian interleukin-1
 
b
 
 converting enzyme (ICE) (5, 6).
The demonstration that overexpression of Ced-3 or ICE
induces apoptosis has provided support for involvement of
these cysteine proteases in cell death pathways (7). ICE/
Ced-3 family members include Nedd2/Ich-1, CPP32/
YAMA/apopain, Tx/Ich-2/ICE
 
rel
 
II, ICE
 
rel
 
III, Mch2, Mch3/
ICE-LAP3/CMH-1 (reviewed in reference 8), ICE-LAP6
(9), FLICE/Mch5 (10, 11), and Mch4 (11). ICE cleaves
the precursor of IL-1
 
b
 
 to the active cytokine (6, 12, 13).
Other known substrates of the ICE/Ced-3 family include:
(
 
a
 
) poly (ADP-ribose) polymerase (PARP) which is cleaved
by CPP32, Mch3 and Ced-3, but not ICE (14-16); and (
 
b
 
)
DNA-dependent protein kinase (DNA-PK), the U1 small
nuclear ribonucleoprotein and D4-GDP dissociation inhib-
itor for the Rho family GTPases (D4-GDI), which are
cleaved by CPP32 (17, 18). However, the functional role
of these cleavage products in the induction of apoptosis is
unclear.
The present results demonstrate that PKC
 
d
 
 is cleaved by
CPP32 and not certain other ICE/Ced-3 family members.
We also demonstrate that overexpression of the PKC
 
d
 
 cat-
alytic fragment is involved in the induction of phenotypic
changes that are characteristic of apoptosis.
 
Materials and Methods
 
In Vitro Cleavage of PKC
 
d
 
 and PARP.
 
The full-length PKC
 
d
 
cDNA was cloned into the SpeI and BamH1 sites of a modified
pSV
 
b
 
 plasmid (Clontech, Palo Alto, CA). PKC
 
d
 
(D327A/D330A)
was generated in two steps by overlapping primer extension.
PARP cDNA was generated by PCR cloning. The proteins were
labeled with [
 
35
 
S]methionine by coupled transcription and trans-
lation reactions (Promega, Madison, WI). Labeled proteins were
incubated with 5 
 
m
 
g/ml 
 
Escherichia coli
 
-derived CPP32
 
b
 
 in 50 mM
Hepes (pH 7.5), 10% glycerol, 2.5 mM DTT, and 0.25 mM
EDTA at room temperature for 30 min. The reaction products
were analyzed by electrophoresis in 10-20% SDS–polyacrylamide
gels and then autoradiography. For the kinase assays, full-length
PKC
 
d
 
, PKC
 
d
 
(D327A/D330A), PKC
 
d
 
 catalytic fragment (CF),
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Activation of PKC
 
d
 
 by CPP32
 
and PKC
 
d
 
CF(K-R) were prepared by coupled transcription and
translation. PKC
 
d
 
 and PKC
 
d
 
(D327A/D330A) were incubated with
5 
 
m
 
g/ml CPP32
 
b
 
 at room temperature for 30 min. Protein ki-
nase assays using MBP as a substrate were performed as described
(PKC Assay Kit; GIBCO BRL, Gaithersburg, MD).
 
Analysis of Peptide Proteolysis.
 
Peptides were synthesized and
purified to 
 
z
 
95% by standard methods and confirmed by mass
spectrometry. Reaction mixtures (810 
 
m
 
l) contained: 100 mM
Hepes (pH 7.5), 20% (vol/vol) glycerol, 5 
 
m
 
M dithiothreitol,
0.5 mM EDTA, and 380 ng 
 
N
 
-His CPP32 (19). Peptide sub-
strates were added to final concentrations of 10 
 
m
 
M. The reaction
mixtures were incubated at 30
 
8
 
C. Aliquots were removed at 10
min intervals for 60 min and added to vials containing 3 M HCl
to stop the reactions. The amount of substrate remaining at each
time was quantitated by reverse phase HPLC. Data were fit to the
equation (S
 
t
 
/S
 
o
 
) 
 
5
 
 e
 
2
 
kt
 
, where 
 
k
 
 is the decay rate constant equal
to V
 
max
 
/K
 
m
 
. Observed V
 
max
 
/K
 
m
 
 values were normalized to 1.00
for the PARP peptide.
 
Cell Transfections.
 
Cells were seeded at a density of 1.7 
 
3
 
 10
 
5
 
in each well of 6-well dishes 24 h before transfection. For each
well, 2 
 
m
 
g DNA construct and 0.5 
 
m
 
g pSv
 
b
 
 plasmid containing
 
b
 
-gal were coprecipitated with calcium phosphate. Cells were in-
cubated with the coprecipitate for 30 h at 37
 
8
 
C and then analyzed
by X-gal staining. Cells (1.7 
 
3
 
 10
 
5
 
/well) were also transfected
with 2 
 
m
 
g DNA construct for 30 h at 37
 
8
 
C, fixed with 4%
paraformaldehyde, postfixed with 5% acetic acid in ethanol and
then stained with 5 
 
m
 
g/ml Hoechst dye. For sub-G1 DNA con-
tent, cells transfected by lipofectamine were stained with propid-
ium iodide and monitored by FACScan
 
Ò
 
. Chromatin condensa-
tion was assessed by staining with acridine orange and ethidium
bromide (20).
 
Results and Discussion
 
To determine whether PKC
 
d
 
 is cleaved by one of the
known ICE-like proteases, full-length 78-kD PKC
 
d
 
 la-
beled with [
 
35
 
S]methionine was incubated with purified re-
combinant proteases. Cleavage of PKC
 
d
 
 to a 40-kD frag-
ment was observed with purified CPP32
 
b
 
 (14) (Fig. 1 
 
A
 
).
In contrast, ICE failed to cleave PKC
 
d
 
 at concentrations up
to 600 U/
 
m
 
l (3). The related Ich-1, Ich-2, Mch2, Mch3,
and ICE
 
rel
 
III proteases also failed to cleave PKC
 
d
 
 (data not
shown). Because PKC
 
d
 
 is cleaved at DMQD
 
330
 
N in vivo
(3, 4), we asked whether this site is responsible for CPP32-
mediated cleavage in vitro. CPP32 may prefer peptidic
substrates with aspartic acid at the P1 and P4 positions (15).
Consequently, we prepared a PKC
 
d
 
 mutant with substitu-
tion of D327A and D330A. Incubation with CPP32 re-
sulted in no detectable CPP32-mediated cleavage of this
Figure 1. PKCd is proteolytically activated by CPP32 in vitro. (A)
PKCd (full-length: FL), PKCd(D327A/D330A) and PARP were labeled
with [35S]methionine and incubated with recombinant CPP32b. The re-
action products were analyzed by SDS-PAGE and autoradiography. The
kinase active PKCd catalytic fragment (CF) and the kinase inactive
PKCdCF(K-R) were labeled with [35S]methionine and analyzed under
similar conditions. (B) Recombinant PKCd and PKCd (D327A/D330A)
were incubated with CPP32 and then assayed for protein kinase activity
using MBP as substrate.
mutant to the 40-kD catalytic fragment, while there was
partial digestion to a species of z55 kD (not observed with
wild-type substrate) (Fig. 1 A). Recombinant CPP32 also
cleaved the 116-kD full-length PARP to the predicted
85-kD fragment (14, 15) (Fig. 1 A). Using peptides derived
Table 1. CPP32 Proteolysis of Peptides Spanning the PARP, 
PKCd, and IL-1b Cleavage Sites
Substrate Sequence
Relative
Vmax/Km
PARP Ac-WGDEVD216-GVDEVW-NH2 1.00
PKCd Ac-GEDMQD330NSGTYW-NH2 0.42
IL-1b Ac-NEAYVHD116APVRSLY-NH2 0.002401 Ghayur et al. Brief Definitive Report
from the cleavage sites of PARP and PKCd in proteolytic
assays, we found that CPP32 cleaves both substrates and
not a peptide spanning the IL-1b maturation site (Table 1).
These findings confirm that PKCd, like PARP, is a sub-
strate for CPP32.
We also asked whether cleavage of PKCd by CPP32 is
associated with activation of the kinase function. Full-
length PKCd exhibited a low level of myelin basic protein
(MBP) phosphorylation, while incubation with CPP32 re-
sulted in a greater than sixfold increase in kinase activity
(Fig. 1 B). In contrast, CPP32 had no detectable effect on ki-
nase function of the PKCd(D327A/D330A) mutant (Fig. 1
B). A recombinant 40-kD CF of PKCd (amino acids 331-
676) exhibited constitutive kinase activity, while a mutant
of the fragment with K-378 in the ATP binding site mu-
tated to R (K378R; designated K-R) yielded background
levels of MBP phosphorylation found with control bacterial
lysates (Figs. 1, A and B). These findings collectively dem-
onstrate that CPP32-mediated cleavage of the DMQD330N
site activates PKCd.
To study the role of PKCd in apoptosis, we used the
transient HeLa cell transfection system previously found to
demonstrate induction of apoptosis by ICE-like proteases
(7). Cotransfection of the kinase inactive PKCdCF(K-R)
mutant with the b-galactosidase (b-gal) marker gene had
little effect on HeLa cell morphology (Fig. 2 A). Most of
the blue X-gal positive cells remained flat and attached to
the dish (Fig. 2 A). Cotransfection of the kinase active
PKCdCF and b-gal resulted in condensed, small blue cells
(Fig. 2 B), consistent with the induction of apoptosis (7).
Similar findings were obtained with NIH3T3 cells (Figs. 2,
C and D). Overexpression of PKCd in both cell types also
Figure 2. Transfection of the PKCd catalytic fragment (CF) induces morphologic changes characteristic of apoptosis. HeLa (upper panels) and NIH3T3
(lower panels) cells were cotransfected with pSvb-b-gal and vectors expressing: (A and C) kinase inactive PKCdCF(K-R) and (B and D) kinase active
PKCdCF. Transfection was determined by X-gal staining and apoptotic cells were identified by their condensed morphology.2402 Activation of PKCd by CPP32
resulted in detachment of non-viable cells into the culture
medium.
Hoechst staining of HeLa cells transfected with a vector
that expresses full-length PKCd had no detectable changes
in nuclear morphology (Fig. 3 A), but overexpression of
PKCdCF resulted in fragmented nuclei (Fig. 3 B). Trans-
fection of kinase inactive PKCdCF(K-R) was associated
with a normal nuclear morphology (Fig. 3 C). The changes
observed with expression of the PKCd CF were also com-
pared to those found upon exposure to 1-b-d-arabinofura-
Figure 3. Expression of PKCdCF results in nuclear fragmentation. HeLa cells were transfected with vectors that express: (A) full-length PKCd; (B) ki-
nase active PKCdCF; and (C) kinase inactive PKCdCF(K-R). (D) Cells were exposed to 2 mM ara-C. The cells were fixed with paraformaldehyde and
then stained with Hoechst dye. Cotransfection of PKCdFL, PKCdCF and PKCdCF(K-R) with pSvb-b-gal demonstrated transfection efficiencies of 50,
42, and 43%, respectively. Percentage of apoptotic cells for the PKCdFL, PKCdCF, and PKCdCF(K-R) transfected populations was 2, 26, and 4%, re-
spectively. Bar, 15 mM.
Figure 4. Overexpression of PKCdCF induces sub-G1 DNA and
chromatin condensation. (A) HeLa cells were transfected with PKCdFL,
PKCdCF, or PKCdCF(K-R). Cells were assessed for DNA content by
flow cytometry at 48 h after transfection. The small triangle denotes G0/G1
DNA. (B) HeLa cells transfected with PKCdCF(K-R) (left) and PKCdCF
(right) were assessed for chromatin condensation after staining with acri-
dine orange and ethidium bromide.2403 Ghayur et al. Brief Definitive Report
that the kinase active catalytic domain of PKCd induces
characteristics typical of cells undergoing apoptosis: (a) size
reduction and round morphology; (b) nuclear fragmenta-
tion; (c) chromatin condensation; (d) sub-G1 DNA con-
tent; and (e) detachment and loss of viability.
Multiple events that lead to destruction of nuclear and
cytoplasmic integrity are probably required for apoptosis.
Activation of ICE-family proteases may be a central trigger,
resulting in the cleavage of substrates such as PARP (21),
lamin B1 (22, 23), topoisomerase 1 (23), D4-GDI (18),
DNA-PK, and the U1 small nuclear ribonucleoprotein
(17). PKCd, but not PKCa, b, e, or z, is also cleaved at the
onset of apoptosis (3, 4). Little is known about the physio-
logical function of PKCd (24, 25). We demonstrate that
PKCd is cleaved by CPP32 and not other ICE/Ced-3 fam-
ily members in vitro. The results also demonstrate that ex-
pression of the PKCd catalytic fragment induces morpho-
logic changes characteristic of apoptosis. We propose that
the proteolytic cleavage of PKCd is a key mediator of nu-
clear fragmentation and cell death, and not a bystander ef-
fect of protease activation. Moreover, the finding that pro-
teolytic activation of PKCd is blocked by Bcl-2 and Bcl-xL
suggests that these anti-apoptotic proteins act upstream to
this event (3). Elucidation of the substrates phosphorylated
as a consequence of PKCd cleavage should provide insights
into the pathways activated by the catalytic fragment.
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